MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer

Molecular Carcinogenesis

Volumn 55, Issue 5, 2016, Pages 768-777

  Zhang, Li ^a   Ma, Ping ^a   Sun, Li Mei ^a   Han, Yan Chun ^a   Li, Bai Lin ^a   Mi, Xiao Yi ^a   Wang, En Hua ^a   Song, Min ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MiR 107; MiRNAs; SIAH1; Triple negative breast cancer

Indexed keywords

MICRORNA 107; PROTEIN; SEVEN IN ABSENTIA HOMOLOG PROTEIN; UNCLASSIFIED DRUG; MICRORNA; MIRN107 MICRORNA, HUMAN; NUCLEAR PROTEIN; SEVEN IN ABSENTIA PROTEINS; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER CELL; CELL INVASION; CELL MIGRATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MCF 7 CELL LINE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; TRIPLE NEGATIVE BREAST NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 84927130361     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22320     Document Type: Article

References (32)

1. Lin Y, Yin W, Yan T, et al. Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer 2009; 9:342.
2. Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin Cancer Res 2007; 13:4429-4434.
3. Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 2008; 26:1275-1281.
4. Tseng LM, Hsu NC, Chen SC, et al. Distant metastasis in triple-negative breast cancer. Neoplasma 2013; 60:290-294.
5. Khotskaya YB, Goverdhan A, Shen J, et al. S6K1 promotes invasiveness of breast cancer cells in a model of metastasis of triple-negative breast cancer. Am J Transl Res 2014; 6:361-376.
6. Wang J, Tsouko E, Jonsson P, et al. MiR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer. Mol Oncol 2014; (Epub ahead of print).
7. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
8. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005; 132:4653-4662.
9. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008; 5:115-119.
10. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101:2999-3004.
11. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 2005; 353:1768-1771.
12. Hu G, Chung YL, Glover T, Valentine V, Look AT, Fearon ER. Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics 1997; 46:103-111.
13. Wen YY, Yang ZQ, Song M, et al. The Expression of SIAH1 is down regulated and associated with Bim and apoptosis in human breast cancer tissues and cells. Mol Carcinog 2010; 49:440-449.
14. Wen YY, Yang ZQ, Song M, Li BL, Zhu JJ, Wang EH. SIAH1 induced apoptosis by activation of the JNK pathway and inhibited invasion by inactivation of the ERK pathway in breast cancer cells. Cancer Sci 2010; 101:73-79.
15. Rotkrua P, Shimada S, Mogushi K, Akiyama Y, Tanaka H, Yuasa Y. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br J Cancer 2013; 108:932-940.
16. Li F, Liu B, Gao Y, et al. Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. FEBS Lett 2014; 588:538-544.
17. Shrestha S, Hsu SD, Huang WY, et al. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med 2014; 3:878-888.
18. Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012; 27:1759-1764.
19. Chen HY, Lin YM, Chung HC, et al. MiR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 2012; 72:3631-3641.
20. Sharma P, Saraya A, Gupta P, Sharma R. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers 2013; 18:322-330.
21. Luo G, Long J, Cui X, et al. Highly lymphatic metastatic pancreatic cancer cells possess stem cell-like properties. Int J Oncol 2013; 42:979-984.
22. Wang WX, Kyprianou N, Wang X, Nelson PT. Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group. Cancer Res 2010; 70:9137-9142.
23. Ayala de la Pena F, Kanasaki K, Kanasaki M, Tangirala N, Maeda G, Kalluri R. Loss of p53 and acquisition of angiogenic microRNA profile is insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 2011; 286:20778-20787.
24. Chen L, Zhang R, Li P, et al. P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Neurosci Lett 2013; 534:327-332.
25. Piao L, Zhang M, Datta J, et al. Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma. Mol Ther 2012; 20:1261-1269.
26. Datta J, Smith A, Lang JC, et al. MicroRNA-107 functions as a candidate tumor suppressor gene in head and neck squamous cell carcinoma by down-regulation of protein kinase Cε. Oncogene 2012; 31:4045-4053.
27. Chen PS, Su JL, Cha ST, et al. MiR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 2011; 121:3442-3455.
28. Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438:685-689.
29. Hu Q, Gong JP, Li J, et al. Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells. Asian Pac J Cancer Prev 2014; 15:5137-5142.
30. Ell B, Qiu Q, Wei Y, et al. The MicroRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. J Biol Chem 2014; 289:21888-21895.
31. Li J, Li X, Kong X, Luo Q, Zhang J, Fang L. MiRNA-26b inhibits cellular proliferation by targeting CDK8 in breast cancer. Int J Clin Exp Med 2014; 7:558-565.
32. Zhu J, Zheng Z, Wang J, et al. Different miRNA expression profiles between human breast cancer tumors and serum. Front Genet 2014; 5:149.